Article
Patients with HCV and F1 and F2 fibrosis stage: treat now or wait?
Liver international : official journal of the International Association for the Study of the Liver - 1 Feb 2013
Shiffman Mitchell L, Benhamou Yves
Abstract excerpt
The current standard of care (SOC) for patients with chronic HCV genotype 1 is a combination of either boceprevir or telaprevir with peginterferon (PEG-IFN) and ribavirin (RBV). Although it is effective in a high percentage of patients, this treatment is associated with significant adverse events (AEs). The next generation of protease inhibitors, simeprevir and faldaprevir, will also be used with PEG-IFN/RBV....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.